-
公开(公告)号：ZA838571B
公开(公告)日：1984-07-25
申请号：ZA838571
申请日：1983-11-17
Applicant: BASF AG
Inventor： FRANKE ALBRECHT , STEINER GERD , HOFMANN HANS-PETER , MUELLER CLAUS-DIETER , TESCHENDORF HANS-JUERGEN
IPC: A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/425 , A61K31/428 , A61P25/20 , A61P25/24 , A61P25/26 , C07D209/46 , C07D209/48 , C07D275/04 , C07D275/06 , C07D495/04 , C07D513/04 , A61K , C07D
-
公开(公告)号：CA1170258A
公开(公告)日：1984-07-03
申请号：CA387495
申请日：1981-10-07
Applicant: BASF AG
Inventor： STEINER GERD , TESCHENDORF HANS-JUERGEN , KREISKOTT HORST , HOFMANN HANS P
IPC: A61K31/55 , A61P25/00 , A61P25/08 , A61P25/20 , C07D223/00 , C07D333/00 , C07D495/14
Abstract: of the disclosure: 5-substituted 9-cyanomethyl-ene-dithieno¢3,4-b:4',3'-e!-azepines, processes for thelr preparation, and therapeutic agents which contain these compounds and can be used as sedatives, hypnotlc drugs, tranquilizers, neuroleptic drugs or anti-Parkinson drugs.
-
公开(公告)号：DK527183D0
公开(公告)日：1983-11-17
申请号：DK527183
申请日：1983-11-17
Applicant: BASF AG
Inventor： FRANKE ALBRECHT , STEINER GERD , HOFMANN HANS PETER , MUELLER CLAUS D , TESCHENDORF HANS-JUERGEN
IPC: A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/425 , A61K31/428 , A61P25/20 , A61P25/24 , A61P25/26 , C07D209/46 , C07D209/48 , C07D275/04 , C07D275/06 , C07D495/04 , C07D513/04 , C07D275
-
公开(公告)号：ZA828127B
公开(公告)日：1983-10-26
申请号：ZA828127
申请日：1982-11-05
Applicant: BASF AG
Inventor： KROPP RUDOLF , THYES MARCO , SCHLECKER RAINER , FRANKE ALBRECHT , REICHENEDER FRANZ , AMANN AUGUST , TESCHENDORF HANS-JUERGEN , KRETZSCHMAR ROLF , TRAUT MARTIN , GRIES JOSEF
IPC: A61K31/50 , A61P9/02 , A61P25/00 , A61P25/24 , A61P25/26 , C07D237/20 , C07D237/22 , A61K , C07D
-
公开(公告)号：NO810761L
公开(公告)日：1981-09-09
申请号：NO810761
申请日：1981-03-05
Applicant: BASF AG
Inventor： STEINER GERD , HOFMAN HANS PETER , KREISKOTT HORST , TESCHENDORF HANS-JUERGEN , LENKE DIETER
IPC: A61K31/275 , C07D295/14 , A61K31/395 , A61K31/50 , A61K31/55 , A61P25/20 , C07C67/00 , C07C253/00 , C07C255/37 , C07C255/42 , C07D243/08 , C07D295/08 , C07D295/155 , C07D
Abstract: 10-Substituted 5-cyanomethylene-dibenzo[a,d]-cycloheptenes, their pure cis- and trans-isomers, their N-oxides and their pharmaceutically tolerated addition salts with acids, processes for their preparation, therapeutic agents containing these compounds and their use as drugs, especially as sedatives, hypnotics or tranquilizers.
-
Patent Agency Ranking
公开(公告)号：DD150602A5
公开(公告)日：1981-09-09
申请号：DD22101680
申请日：1980-05-09
Applicant: BASF AG
Inventor： STEINER GERG , FRANKE ALBRECHT , LENKE DIETER , TESCHENDORF HANS-JUERGEN , WORSTMANN WOLFGANG , KREISKOTT HORST
IPC: A61K31/55 , A61P25/18 , C07D223/20 , C07D401/06 , C07D403/04
Abstract: 6-Substituted 11-alkylene-morphanthridines, also referred to as 11-alkylene-dibenzo[b,e]-azepines, their pure cis- and trans-isomers, processes for their preparation, and therapeutic agents containing these compounds, which may be used as drugs, in particular neuroleptics, sedatives, hypnotics, analgesics, antidepressants or agents for treating Parkinson's syndrome.
-
公开(公告)号：NO801387L
公开(公告)日：1980-11-11
申请号：NO801387
申请日：1980-05-09
Applicant: BASF AG
Inventor： STEINER GERD , FRANKE ALBRECHT , LENKE DIETER , TESCHENDORF HANS-JUERGEN , WORSTMANN WOLFGANG , KREISKOTT HORST
IPC: A61K31/55 , A61P25/18 , C07D223/20 , C07D401/06 , C07D403/04 , C07D
Abstract: 6-Substituted 11-alkylene-morphanthridines, also referred to as 11-alkylene-dibenzo[b,e]-azepines, their pure cis- and trans-isomers, processes for their preparation, and therapeutic agents containing these compounds, which may be used as drugs, in particular neuroleptics, sedatives, hypnotics, analgesics, antidepressants or agents for treating Parkinson's syndrome.
-
公开(公告)号：DE59905342D1
公开(公告)日：2003-06-05
申请号：DE59905342
申请日：1999-07-20
Applicant: BASF AG
Inventor： STEINER GERD , HOEGER THOMAS , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , JUCHELKA FRIEDER
IPC: A61K31/4184 , A61P25/20 , A61P25/24 , A61P25/30 , C07D403/06
Abstract: The invention relates to compounds of formula (1), wherein R , R and R have the meaning cited in the description. The novel substances are suitable for use in disease control.
-
公开(公告)号：DE59510635D1
公开(公告)日：2003-05-15
申请号：DE59510635
申请日：1995-07-14
Applicant: BASF AG
Inventor： HELLENDAHL BEATE , LANSKY ANNEGRET , RENDENBACH-MUELLER BEATRICE , BACH ALFRED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE CARSTEN
IPC: C07D233/84 , A61K31/33 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4425 , A61K31/445 , A61K31/495 , A61K31/496 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , C07D213/56 , C07D213/64 , C07D213/65 , C07D213/70 , C07D213/73 , C07D213/79 , C07D213/81 , C07D233/90 , C07D307/79 , C07D333/24 , C07D333/28 , C07D333/38 , C07D471/18
Abstract: PCT No. PCT/EP95/02782 Sec. 371 Date Jan. 14, 1997 Sec. 102(e) Date Jan. 14, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02246 PCT Pub. Date Feb. 1, 1996The present invention relate to the use of heterocyclic compounds of the following formula:Het-A-B-Arwhere Het, A, B and Ar have the meanings stated in the description. The compounds according to the invention have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
-
公开(公告)号：AT236629T
公开(公告)日：2003-04-15
申请号：AT95926896
申请日：1995-07-14
Applicant: BASF AG
Inventor： HELLENDAHL BEATE , LANSKY ANNEGRET , RENDENBACH-MUELLER BEATRICE , BACH ALFRED , UNGER LILIANE , TESCHENDORF HANS-JUERGEN , WICKE CARSTEN
IPC: C07D233/84 , A61K31/33 , A61K31/415 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4425 , A61K31/445 , A61K31/495 , A61K31/496 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , C07D213/56 , C07D213/64 , C07D213/65 , C07D213/70 , C07D213/73 , C07D213/79 , C07D213/81 , C07D233/90 , C07D307/79 , C07D333/24 , C07D333/28 , C07D333/38 , C07D471/18
Abstract: PCT No. PCT/EP95/02782 Sec. 371 Date Jan. 14, 1997 Sec. 102(e) Date Jan. 14, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02246 PCT Pub. Date Feb. 1, 1996The present invention relate to the use of heterocyclic compounds of the following formula:Het-A-B-Arwhere Het, A, B and Ar have the meanings stated in the description. The compounds according to the invention have a high affinity for the dopamine D3 receptor and can therefore be used to treat disorders which respond to dopamine D3 ligands.
-
-
-
-
-
-
-
-
-
Search Results
400
records
(took 0.024 seconds)
